TBRIF (Therma Bright) Institutional Ownership : 0.64% (As of Dec. 13, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Therma Bright Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Therma Bright's institutional ownership is 0.64%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Therma Bright's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Therma Bright's Float Percentage Of Total Shares Outstanding is 0.00%.

Therma Bright Institutional Ownership Historical Data

The historical data trend for Therma Bright's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therma Bright Institutional Ownership Chart

Therma Bright Historical Data

The historical data trend for Therma Bright can be seen below:

	2017-04-30	2017-05-31	2017-06-30	2017-07-31
Institutional Ownership	0.67	0.67	0.67	0.64

Therma Bright Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Therma Bright Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Therma Bright Inc (OTCPK:TBRIF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

THRM:Canada

Address

345 Danforth Avenue, Toronto, ON, CAN, M4K 1N7

Website

https://www.thermabright.com

Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on 3 key strategic areas: respiratory disease, vascular health, and consumer medical devices.